Table 4.
Densitometry characterization at baseline and calcium and cholecalciferol supplementation
| All patients | Group A | Group B | Group C | |
|---|---|---|---|---|
| (n = 174) | (n = 76) | (n = 69) | (n = 29) | |
| First evaluation, n (%) | ||||
| Lumbar spine | ||||
| Normal | 98 (56) | 37 (49) | 45 (65) | 16 (55) |
| Osteopenia | 35 (20) | 15 (20) | 15 (22) | 5 (17) |
| Osteoporosis | 18 (10) | 9 (12) | 3 (4) | 6 (21) |
| Unknown/not available | 23 (13) | 15 (20) | 6 (9) | 2 (8) |
| Femoral neck | ||||
| Normal | 104 (60) | 41 (54) | 47 (68) | 16 (55) |
| Osteopenia | 33 (19) | 11 (14) | 13 (19) | 9 (31) |
| Osteoporosis | 8 (5) | 5 (7) | 1 (1) | 2 (7) |
| Unknown/not available | 29 (17) | 19 (25) | 8 (12) | 2 (7) |
| Calcium/cholecalciferol supplementation, n (%) | 73 (42) | 30 (39) | 31 (45) | 12 (41) |